Advertisement

Ösophaguskarzinom beim alten und geriatrischen Patienten

  • Florian Lordick
  • Ines Gockel
  • Joachim Mössner
Chapter
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Ösophaguskarzinome sind Erkrankungen des Erwachsenen und zeigen eine zunehmende Prävalenz mit steigendem Lebensalter. Plattenepithelkarzinome entstehen vorwiegend auf der Grundlage jahrelangen Tabak- und Alkoholkonsums; Adenokarzinome finden sich assoziiert mit Adipositas und chronischer gastro-ösophagealer Refluxkrankheit. Die kurative Behandlung des Ösophaguskarzinoms erfolgt multimodal in den meist bei Diagnosestellung anzutreffenden lokal fortgeschrittenen Stadien. Die Therapie-assoziierten Risiken sind dabei besonders zu beachten. Ein exzellentes Risikomanagement, gerade bei Begleiterkrankungen und eingeschränkten Organfunktionen ist von großer Wichtigkeit. Dies setzt gerade bei älteren Patienten eine große Erfahrung und Expertise des Zentrums voraus. Die wissenschaftliche Evidenz für die Behandlung von Ösophaguskarzinomen im höheren Lebensalter ist noch dürftig.

Literatur

  1. van Adrichem EJ, Meulenbroek RL et al (2014) Comparison of two preoperative inspiratory muscle training programs to prevent pulmonary complications in patients undergoing esophagectomy: a randomized controlled pilot study. Ann Surg Oncol 21:2353–2360PubMedGoogle Scholar
  2. Agrelli TF, de Carvalho RM et al (2012) Preoperative ambulatory inspiratory muscle training in patients undergoing esophagectomy. A pilot study. Int Surg 97:198–202CrossRefPubMedPubMedCentralGoogle Scholar
  3. Al-Batran SE, Hartmann JT et al (2008) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 26:1435–1442CrossRefPubMedGoogle Scholar
  4. Al-Batran SE, Pauligk C et al (2013) The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+). Eur J Cancer 49:835–842CrossRefPubMedGoogle Scholar
  5. Bedenne L, Michel P et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168CrossRefPubMedGoogle Scholar
  6. Bellera CA, Rainfray M et al (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23:2166–2172CrossRefPubMedGoogle Scholar
  7. Biere SS, van Berge Henegouwen MI et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1982CrossRefPubMedGoogle Scholar
  8. Bleiberg H, Conroy T et al (1997) Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33:1216–1220CrossRefPubMedGoogle Scholar
  9. Blom RL, van Heijl M et al (2013) Initial experiences of an enhanced recovery protocol in esophageal surgery. World J Surg 37:2372–2378CrossRefPubMedGoogle Scholar
  10. Bozzetti F (2015) Tube feeding in the elderly cancer patient. Nutrition 31:608–609CrossRefPubMedGoogle Scholar
  11. Bytzer P, Christensen PB et al (1999) Adenocarcinoma of the esophagus and Barrett’s esophagus: a population-based study. Am J Gastroenterol 94:86–91CrossRefPubMedGoogle Scholar
  12. Cao S, Zhao G et al (2012) Fast-track rehabilitation program and conventional care after esophagectomy: a retrospective controlled cohort study. Support Care Cancer 21:707–714CrossRefPubMedGoogle Scholar
  13. Castro C, Bosetti C et al (2014) Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol 25:283–290CrossRefPubMedGoogle Scholar
  14. Colloca G, Tosato M, Zuccalà G, Bernabei R (2005) Preoperative assessment and risk factors in the surgical treatment of esophageal cancer: the role of age. Rays 30:335–339PubMedGoogle Scholar
  15. Decoster L, Van Puyvelde K (2015) Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 26:288–300CrossRefPubMedGoogle Scholar
  16. Dettling DS, van der Schaaf M et al (2013) Feasibility and effectiveness of pre-operative inspiratory muscle training in patients undergoing oesophagectomy: a pilot study. Physiother Res Int 18:16–26CrossRefPubMedGoogle Scholar
  17. Ell C, May A et al (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118:670–677CrossRefPubMedGoogle Scholar
  18. El-Serag HB, Hashmi A et al (2014) Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut 63:220–229PubMedGoogle Scholar
  19. Ferlay J, Steliarova-Foucher E et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMedGoogle Scholar
  20. van Hagen P, Hulshof MC et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084CrossRefPubMedGoogle Scholar
  21. Homs MY, Steyerberg EW et al (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364:1497–1504CrossRefPubMedGoogle Scholar
  22. Hurria A, Browner IS et al (2012) Senior adult oncology. J Natl Compr Canc Netw 10:162–209CrossRefPubMedPubMedCentralGoogle Scholar
  23. Hvid-Jensen F, Pedersen L et al (2011) Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 365:1375–1383CrossRefPubMedGoogle Scholar
  24. Inoue J, Ono R et al (2013) Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer. Dis Esophagus 26:68–74CrossRefPubMedGoogle Scholar
  25. Koop H, Fuchs KH et al (2014) S2k-Leitlinie: Gastroösophageale Refluxkrankheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten, DGVS, AWMF Registrier-Nummer 021–013. Z Gastroenterol 52:1299–1346CrossRefPubMedGoogle Scholar
  26. Kosugi S, Sasamoto R, Kanda T, Matsuki A, Hatakeyama K (2009) Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older. Jpn J Clin Oncol 39:360–366CrossRefPubMedGoogle Scholar
  27. Lagergren J, Bergström R et al (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831CrossRefPubMedGoogle Scholar
  28. Li J, Shen Y et al (2015) Is minimally invasive esophagectomy beneficial to elderly patients with esophageal cancer? Surg Endosc 29:925–930CrossRefPubMedGoogle Scholar
  29. Lordick F (2012) Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography. Recent Results Cancer Res 196:201–211CrossRefPubMedGoogle Scholar
  30. Lordick F, Ott K et al (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8:797–805CrossRefPubMedGoogle Scholar
  31. Lordick F, Mariette C, Haustermans K, Obermannová R, Arnold D on behalf of the ESMO Guideline Committee (2016) Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(Sep, suppl 5):v50–v57Google Scholar
  32. Lorenzen S, Pauligk C et al (2013) Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer. Br J Cancer 108:519–526CrossRefPubMedPubMedCentralGoogle Scholar
  33. Manzano JG, Luo R, Elting LS, George M, Suarez-Almazor ME (2014) Patterns and predictors of unplanned hospitalization in a population-based cohort of elderly patients with GI cancer. J Clin Oncol 32:3527–3533CrossRefPubMedPubMedCentralGoogle Scholar
  34. Mariette C, Meunier B et al (2015) Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trial. J Clin Oncol 33(Suppl 3), Abstract 5Google Scholar
  35. McLoughlin JM, Lewis JM et al (2013) The impact of age on morbidity and mortality following esophagectomy for esophageal cancer. Cancer Control 20:144–150CrossRefPubMedGoogle Scholar
  36. Miyata H, Yamasaki M et al (2015) Clinical outcome of esophagectomy in elderly patients with and without neoadjuvant therapy for thoracic esophageal cancer. Ann Surg Oncol 22:794–801CrossRefGoogle Scholar
  37. Oakley B, Lamb C et al (2016) Achieving long term survival in oesophagectomy patients aged over 75. Ann Med Surg (Lond) 9:15–21CrossRefGoogle Scholar
  38. Pech O, May A et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660CrossRefPubMedGoogle Scholar
  39. Phoa KN, van Vilsteren FG et al (2014) Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 311:1209–1217CrossRefPubMedGoogle Scholar
  40. Phoa KN, Pouw RE et al (2016) Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut 65:555–562CrossRefPubMedGoogle Scholar
  41. Popa MA, Wallace KJ, Brunello A, Extermann M, Balducci L (2014) Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy. J Geriatr Oncol 5:307–314CrossRefPubMedPubMedCentralGoogle Scholar
  42. Puntambekar S, Kenawadekar R et al (2013) Minimally invasive esophagectomy in the elderly. Indian J Surg Oncol 4:326–331CrossRefPubMedPubMedCentralGoogle Scholar
  43. Rice DC, Correa AM et al (2005) Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79:391–397CrossRefPubMedGoogle Scholar
  44. Rustgi AK, El-Serag HB (2014) Esophageal carcinoma. N Engl J Med 371:2499–2509CrossRefPubMedGoogle Scholar
  45. Schoppmeyer K, Golsong J et al (2007) Antireflux stents for palliation of malignant esophagocardial stenosis. Dis Esophagus 20:89–93CrossRefPubMedGoogle Scholar
  46. Shaheen NJ, Sharma P et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288CrossRefPubMedGoogle Scholar
  47. Stahl M, Stuschke M et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317CrossRefPubMedGoogle Scholar
  48. Stahl M, Walz MK et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856CrossRefPubMedGoogle Scholar
  49. Steyerberg EW, Neville BA et al (2006) Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 24:4277–4284CrossRefPubMedGoogle Scholar
  50. Waddell T, Verheij M et al (2013) Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi57–vi63CrossRefPubMedGoogle Scholar
  51. Wilke H, Muro K et al (2014) Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol 15:1224–1235CrossRefPubMedGoogle Scholar
  52. Won E, Ilson DH (2014) Management of localized esophageal cancer in the older patient. Oncologist 19:367–374CrossRefPubMedPubMedCentralGoogle Scholar
  53. Wouters MW, Wijnhoven BP et al (2008) High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol 15:80–87CrossRefPubMedGoogle Scholar
  54. Yamamoto M, Yamasaki M, Sugimoto K, Maekawa Y, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Rakugi H, Mori M, Doki Y. Risk Evaluation of Postoperative Delirium Using Comprehensive Geriatric Assessment in Elderly Patients with Esophageal Cancer. World J Surg 40(11):2705–2712Google Scholar
  55. Yamana I, Takeno S et al (2015) Is the geriatric nutritional risk index a significant predictor of postoperative complications in patients with esophageal cancer undergoing esophagectomy? Eur Surg Res 55:35–42CrossRefPubMedGoogle Scholar
  56. Zhu HD, Guom JH et al (2014) Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial. Lancet Oncol 15:612–619CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  • Florian Lordick
    • 1
  • Ines Gockel
    • 2
  • Joachim Mössner
    • 3
  1. 1.University Cancer Center Leipzig (UCCL)University Medicine LeipzigLeipzigDeutschland
  2. 2.Klinik und Poliklinik für Visceral-, Transplantations-, Thorax- und GefäßchirurgieUniversitätsklinikum LeipzigLeipzigDeutschland
  3. 3.Klinik und Poliklinik für Gastroenterologie und RheumatologieUniversitätsklinikum LeipzigLeipzigDeutschland

Section editors and affiliations

  • Nicolai Härtel
    • 1
  1. 1.Interdisziplinäres TumorzentrumUniversitätsmedizin MannheimMannheimDeutschland

Personalised recommendations